Results 181 to 190 of about 59,240 (301)

ATTITUDES AND PRACTICE PATTERNS OF CANADIAN PHYSIATRISTS REGARDING MEDICAL CANNABIS. [PDF]

J Rehabil Med Clin Commun
Ethans K, Chaudhary H, Casey A, O'Connell C, Nankar M, Khandelwal A.   +5 more
europepmc   +1 more source

Collaborative care intervention for risky opioid use among primary care patients: The STOP randomized clinical trial

Addiction, EarlyView.
Abstract Background and aims Individuals who engage in illicit or nonmedical opioid use may have elevated risk of health and social consequences, including progression to opioid use disorder (OUD). Preventive interventions to reduce this risk are lacking. This trial tested the impact of a primary care‐integrated collaborative care approach for reducing
Jennifer McNeely, Geetha A. Subramaniam, Rebecca Stone, Shayna Mazel, Noa Appleton, Yasna Rostam‐Abadi, Amanda M. Bunting, Yidan Shi, Travis I. Lovejoy, Lillian Gelberg, Donna Beers, Margaret Kline, Song Zhang, Tobie Kim, Ashley Case, Jennifer McCormack, Michael A. Incze, Jane M. Liebschutz, the STOP trial site principal investigators, Karen Alexander, Seuli Bose Brill, Sarah Kawasaki, Adam J. Gordon, Hyunouk Hong   +23 more
wiley   +1 more source

Prevalence and risk perceptions of nicotine pouch use: A systematic review of population‐based studies

Addiction, EarlyView.
Abstract Background and Aims Oral nicotine pouches (NPs) are a new class of non‐combustible nicotine products that have gained rapid popularity. Despite rising sales and marketing, evidence of their prevalence and risk perceptions remains limited. This systematic review aimed to synthesize the available global evidence on the prevalence and patterns of
Salma Mahmoodianfard, Spencer Shahen, Javad Heshmati, Emma Bates, Evyanne Quirouette, Terefe Gelibo, Sarah Visintini, Hassan Mir   +7 more
wiley   +1 more source

Trends in new psychoactive substance poisonings in the Netherlands: A 14‐year retrospective analysis (2012–2025)

Addiction, EarlyView.
Abstract Background and aims Data on the presence of new psychoactive substances (NPS) mainly originate from drug‐checking, law enforcement and wastewater analysis sources, while data on NPS poisonings are scarce. In Europe, the documented incidence rate of NPS poisonings is highest in the Netherlands.
Johanna J. Nugteren‐van Lonkhuyzen, Irma S. van den Hengel‐Koot, Claudine C. Hunault, Dylan W. de Lange, Antoinette J. H. P. van Riel, Laura Hondebrink   +5 more
wiley   +1 more source

Cannabis consumer responses to the concept of standard THC units

Addiction, EarlyView.
Abstract Aims Within a context of considerable cannabis market expansion and product diversification, cannabis consumers must manage their use across a range of potencies and modes of consumption. This study aimed to provide deeper understandings of how cannabis consumers would perceive the introduction of a standard THC (tetrahydrocannabinol) unit ...
Mark Pawson, Mike Vuolo, Brian C. Kelly
wiley   +1 more source

Ewing sarcoma-related pain: potential role of medical cannabis monotherapy in symptom management - a case report. [PDF]

J Cannabis Res
De Virgilio Suglia C, Spaccavento FA, Turco F, De Trizio A, Giannuzzi R, Tafuri S.   +5 more
europepmc   +1 more source

The Cannabis Research Image Database (CRESIDA): A standardized and validated image set for studying cannabis cue reactivity

Addiction, EarlyView.
Abstract Background and aims Cannabis cue reactivity paradigms are instrumental in studying the behavioral and neurocognitive mechanisms of cannabis use and cannabis use disorders; however, image sets used for cannabis cue reactivity paradigms vary between studies, and the lack of reliability and validity assessment hinders the quality of evidence they
Janna Cousijn, Emese Kroon, Chao Suo, Tom P. Freeman, Chandni Hindocha, Marianna Quinones‐Valera, Valentina Lorenzetti   +6 more
wiley   +1 more source

From card to cradle: examining medical cannabis purchasing among pregnant women in Arkansas. [PDF]

Am J Obstet Gynecol MFM
ElHassan NO, Farnam C, Thompson JW, Stanley N, Hayes CJ, Li C, Mourani PM, Hudson TJ, Mcgehee R, Martin BC.   +9 more
europepmc   +1 more source

Issues spotlight: Medical cannabis [PDF]

Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, 2018
openaire   +2 more sources

Beyond abstinence: Redefining success in cannabis use disorder treatment

Addiction, EarlyView.
Abstract Background Over two decades of pharmacotherapy research has yet to yield a consistently effective medication for cannabis use disorder (CUD), in part because clinical trials have frequently prioritized abstinence as a primary or key endpoint.
Tobias B. Atkin, Frances R. Levin, John Mariani, Christina A. Brezing   +3 more
wiley   +1 more source